AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 49 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,836,000 | -28.1% | 62,113 | +15.5% | 0.00% | -33.3% |
| Q1 2019 | $2,555,000 | +54.8% | 53,791 | +17.6% | 0.01% | +50.0% |
| Q4 2018 | $1,651,000 | -41.4% | 45,748 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $2,816,000 | +26.3% | 45,748 | +38.5% | 0.01% | +100.0% |
| Q2 2018 | $2,230,000 | +873.8% | 33,034 | +555.7% | 0.00% | +200.0% |
| Q1 2017 | $229,000 | -97.2% | 5,038 | -97.7% | 0.00% | -95.0% |
| Q4 2016 | $8,149,000 | -33.6% | 215,320 | -33.8% | 0.02% | -33.3% |
| Q3 2016 | $12,280,000 | +118.1% | 325,389 | +1.7% | 0.03% | +114.3% |
| Q2 2016 | $5,630,000 | +44.7% | 319,900 | 0.0% | 0.01% | +55.6% |
| Q1 2016 | $3,890,000 | -50.1% | 319,900 | 0.0% | 0.01% | -50.0% |
| Q4 2015 | $7,790,000 | +37.3% | 319,900 | 0.0% | 0.02% | +38.5% |
| Q3 2015 | $5,675,000 | +0.5% | 319,900 | 0.0% | 0.01% | +18.2% |
| Q2 2015 | $5,646,000 | -43.7% | 319,900 | 0.0% | 0.01% | -45.0% |
| Q1 2015 | $10,026,000 | +7.4% | 319,900 | 0.0% | 0.02% | +5.3% |
| Q4 2014 | $9,338,000 | +41.1% | 319,900 | 0.0% | 0.02% | +35.7% |
| Q3 2014 | $6,619,000 | -16.5% | 319,900 | 0.0% | 0.01% | -17.6% |
| Q2 2014 | $7,924,000 | +16.5% | 319,900 | -0.3% | 0.02% | +13.3% |
| Q1 2014 | $6,802,000 | +18.3% | 321,000 | +0.3% | 0.02% | +7.1% |
| Q4 2013 | $5,749,000 | – | 320,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|